Quantcast

Latest National Cancer Institute Stories

2014-09-18 12:29:16

Contract Funds 3D Breast Cancer, 3D Brain Cancer Micro-Tumor Development GREENVILLE, S.C., Sept. 18, 2014 /PRNewswire/ -- KIYATEC announced today that it has been awarded a $1.975 million Small Business Innovation Research (SBIR) Phase II Contract from the National Cancer Institute (NCI), one of the 27 institutes and centers that comprise the National Institutes of Health (NIH). Over the course of the two year award, KIYATEC will expand its 3D breast cancer model to address two...

2014-09-15 23:11:36

A collaborative study between researchers at the University of Colorado Cancer Center and the National Cancer Institute (NCI) published today in the journal Clinical Cancer Research takes an important step toward answering the question: which altered genes are most to blame for bladder cancer? AURORA, Colo. (PRWEB) September 15, 2014 The story of cancer care seems so simple: find the mutated gene that causes cancer and turn it off or fix it. But rarely does a single gene cause cancer....

Transformative Science
2014-09-10 03:22:07

National Science Foundation A new public-private partnership between the National Science Foundation (NSF), National Cancer Institute (NCI), Stand Up To Cancer (SU2C) and The V Foundation for Cancer Research is committing $11.5 million towards transformational, theoretical biophysics that could have a significant impact on cancer research and treatment. SU2C is a program of the Entertainment Industry Foundation, a 501(c)(3) charitable organization that raises money for innovative cancer...

2014-09-08 12:29:17

DENVER, Sept. 8, 2014 /PRNewswire/ -- Pharmatech, Weill Cornell Medical College (WCMC) and 25 other leading oncology practices have agreed to evaluate an innovative program for rapidly identifying and enrolling patients in oncology clinical trials, sponsored by the Small Business Innovative Research (SBIR) grant funded by the National Cancer Institute (NCI). The solution, Just-In-Time (JIT), addresses inefficiencies in the oncology drug-development process, which fails to match the...

2014-09-03 16:29:18

In the news release, Oncolytics Biotech® Inc. Announces Completion of Patient Enrollment in U.S. Randomized Phase 2 Ovarian Cancer Study, issued 03-Sep-2014 by Oncolytics Biotech Inc. over CNW, we are advised by the company that at the end of the fourth paragraph, "150 patients" should read "110 patients". The complete, corrected release follows: Oncolytics Biotech® Inc. Announces Completion of Patient Enrollment in U.S. Randomized Phase 2 Ovarian Cancer Study CALGARY,...

2014-08-18 23:02:59

The anti-cancer drug Xalkori® is being investigated by the ECOG-ACRIN Cancer Research Group in E4512, a phase III trial. Philadelphia, PA (PRWEB) August 18, 2014 People diagnosed with early-stage non-squamous non-small cell lung cancer whose tumors have an altered ALK gene now have the opportunity to participate in a new phase III clinical trial, ECOG-ACRIN announced today. The trial will determine if Xalkori® (generic name crizotinib, an ALK-inhibitor), when used after...

2014-08-18 16:28:13

WASHINGTON, Aug. 18, 2014 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) President & CEO, Laurie Fenton Ambrose praised the National Cancer Institute's (NCI) new trial, launched today, that will focus on the prevention of recurrence in two specific types of lung cancers when they are caught at early stage and surgically removed. "This trial demonstrates the power of CT screening to open new research windows on critical problems, such as recurrence, that have eluded...

2014-08-11 08:28:38

TORONTO, ON and CHICAGO, IL, Aug. 11, 2014 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia") (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, announced today that its subsidiary Pinnacle Biologics, Inc., a biopharmaceutical research and development company specializing in rare diseases, enrolled the first patients in a randomized Phase 2 trial to evaluate...

2014-08-07 16:29:51

By the National Cancer Institute BETHESDA, Md., Aug. 7, 2014 /PRNewswire-USNewswire/ -- In the African-American community, the vast network of Historically Black Colleges and Universities (HBCUs) located around the country are treasured institutions. They are time-honored pathways to education for many African American high school graduates and even today continue to serve as beacons of higher education hope for many young African Americans....

2014-08-01 23:07:36

The Mesothelioma Victims Center is releasing new information this week on where to find the most current and up-to-date news on treatment options from organizations such as the National Cancer Institute. The Center is also urging diagnosed victims of mesothelioma, or their family members to call them at 866-714-6466 for instant access to the nation's most skilled mesothelioma compensation attorneys who consistently get the best financial settlements for victims nationwide....


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related